Van Hulzen Asset Management’s Halozyme HALO Stock Holding History

Van Hulzen Asset Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8	Closed	-$383	–	620
2024 Q4	$383	Buy	+8	New	+$410	﹤0.01%	1106

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Van Hulzen Asset Management's HALO Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 8 shares — an estimated $383 sold.

Van Hulzen Asset Management first reported a position in HALO in Q4 2024 and held it in 1 quarter. The position peaked at $383 in Q4 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

Van Hulzen Asset Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
Van Hulzen Asset Management sold 8 Halozyme shares in Q1 2025, an estimated $383.
Van Hulzen Asset Management first reported a position in Halozyme in Q4 2024 and held it in 1 quarter.
Van Hulzen Asset Management's Halozyme position peaked at $383 in Q4 2024.
550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.